Buprenorphine Is Not the Only Synthetic: Getting L-OUD about Managing Overdose

CE Credit: No CE is offered with this activity.
Activity Fee: Members/Non-Members - Free
Activity Date: December 6, 2022

Overview

In this activity, Drs. Feldman, Koehl, and Zimmerman will identify synthetic opioid contaminants, describe optimal opioid reversal strategies, compare buprenorphine inductions strategies in the emergency department, and recommend harm reduction strategies for patients with opioid use disorder (OUD).

Speakers

• Ryan Feldman, PharmD, BCPS, DABAT, Emergency Medicine Pharmacist/Clinical Toxicologist, Froedtert & The Medical College of Wisconsin
• Jenny Koehl, BCPS, Emergency Medicine Clinical Specialist, Massachusetts General Hospital
• David E. Zimmerman, PharmD, BCCCP, Associate Professor of Pharmacy, Duquesne University School of Pharmacy